The London-based platform, which already covers 1.5 million eligible lives across enterprise and healthcare deployments, is using the Series A to accelerate US market entry and deepen its clinical infrastructure, with a new CEO who sold his last company to Adobe.
JAAQ, the London-based digital health engagement platform, has raised $17 million in a Series A round. The investment comes from Meridian Health Ventures, Fuel Ventures, Bolt Angels, and Guinness Ventures, with the capital allocated to scaling enterprise partnerships, deepening clinical infrastructure, and expanding into the United States. Dr. Pooja Sikka, a partner at Meridian Health Ventures, has joined the company’s board as part of the deal.
The company was founded in 2021 with a direct-to-consumer model built around video-based mental health content. It has since pivoted to an enterprise and healthcare focus, embedding that content library, now more than 10,000 clinically reviewed videos, inside the digital products of insurers, employers, and healthcare organisations rather than distributing it to individual users.
The logic is structural: rather than asking people to seek out a mental health platform, JAAQ places its content inside the apps and services they are already using. It currently covers more than 1.5 million eligible lives through active enterprise deployments.
Alex Packham has joined as CEO to lead the company through its next phase. Packham is best known for ContentCal, a social media management SaaS platform he built and sold to Adobe in December 2021, after which he spent three years leading the product’s integration inside Adobe before departing.
The platform’s commercial proposition has two layers. Organisations can license content from JAAQ’s library and integrate it into their own product journeys, or they can licence a bespoke hosted JAAQ experience.
The company is also building infrastructure it describes as a “clinical engagement layer” for AI-native products, designed to let any digital product or team embed governed mental health content into user journeys without building the clinical governance apparatus themselves.
The pitch to enterprises is that this addresses two problems simultaneously: the mental health access gap, and low engagement with wellbeing benefits that organisations invest in but employees rarely use.
The clinical governance framing is central to how JAAQ differentiates itself from generic AI wellness tools. The platform’s content is produced within a defined clinical and creative framework, rather than generated on demand, and Johri’s appointment is intended to signal that the product is being built with clinical credibility embedded rather than bolted on.
Meridian Health Ventures, which focuses specifically on UK health tech with a pathway into the US market, is a natural fit for that positioning: the firm runs the first NHS-anchored venture fund and has a dedicated Innovations in Mental Health Fund.
The US expansion is the strategic priority the funding is designed to unlock. The UK market has provided validation, the company’s website references case studies including a UK bank that saved £896,000 in employee productivity and wellbeing improvements, and an insurer that deflected the equivalent of twelve full-time customer service roles through JAAQ-served content.
Translating that model into the US employer and health insurer market, where mental health benefits are increasingly a board-level priority but engagement remains a persistent problem, is the next test.
